National Methadone Clinics
About Bayview Hunters Point Foundation
Outpatient care in San Francisco, CA. Payment options listed: Medicare and self-pay.
Bayview Hunters Point Foundation in San Francisco provides outpatient care and operates as an opioid treatment program (OTP). Medication options include methadone, buprenorphine, and naltrexone. The facility also offers care for co-occurring mental health conditions.
CARF accreditation is confirmed.
Finding Bayview Hunters Point Foundation
Here is where Bayview Hunters Point Foundation is and how to reach it.
1625 Carroll Avenue, San Francisco, CA, 94124
Licensing Record and Status
Licensing details have not been independently confirmed. Ask the facility for its license details and verify them with the licensing authority.
Active
Treatment and Services at Bayview Hunters Point Foundation
Here is what Bayview Hunters Point Foundation offers for care options, in plain terms.
Types of Care
- Substance use disorder treatment
- Mental health care
- Combined mental health and substance use treatment
- Outpatient
- Opioid treatment program
- Buprenorphine
- Methadone
- Naltrexone
Who It Serves
- Adolescents
- Young adults
- Adults
- Seniors
- Women
- Men
- Women-only program
- Men-only program
Ways to Pay
- Medicare
- Self-pay
Licences and Accreditation
- Holds a state licence, certification or accreditation
- CARF accreditation
Source: what the facility reported to SAMHSA's treatment locator. Confirm the details with the facility before visiting.
Questions to Ask Bayview Hunters Point Foundation Before You Call
Ask which services are offered, who delivers the care, how admission works and whether there is a wait. Check the full cost, how insurance is handled and any extra charges with the facility itself.
Need Help Comparing Programs?
Treat this directory entry as a starting point for comparing options. Check the facility's services, admission requirements and current availability with the facility itself. A listing here does not endorse the facility or guarantee admission.